BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 16847110)

  • 1. Intraspecific bovine herpesvirus 1 recombinants carrying glycoprotein E deletion as a vaccine marker are virulent in cattle.
    Muylkens B; Meurens F; Schynts F; Farnir F; Pourchet A; Bardiau M; Gogev S; Thiry J; Cuisenaire A; Vanderplasschen A; Thiry E
    J Gen Virol; 2006 Aug; 87(Pt 8):2149-2154. PubMed ID: 16847110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological characterization of bovine herpesvirus 1 recombinants possessing the vaccine glycoprotein E negative phenotype.
    Muylkens B; Meurens F; Schynts F; de Fays K; Pourchet A; Thiry J; Vanderplasschen A; Antoine N; Thiry E
    Vet Microbiol; 2006 Mar; 113(3-4):283-91. PubMed ID: 16321480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A triple gene mutant of BoHV-1 administered intranasally is significantly more efficacious than a BoHV-1 glycoprotein E-deleted virus against a virulent BoHV-1 challenge.
    Chowdhury SI; Wei H; Weiss M; Pannhorst K; Paulsen DB
    Vaccine; 2014 Sep; 32(39):4909-15. PubMed ID: 25066735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization and challenge experiments with a new modified live bovine herpesvirus type 1 marker vaccine prototype adjuvanted with a co-polymer.
    Kalthoff D; König P; Trapp S; Beer M
    Vaccine; 2010 Aug; 28(36):5871-7. PubMed ID: 20600486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection induced by a glycoprotein E-deleted bovine herpesvirus type 1 marker strain used either as an inactivated or live attenuated vaccine in cattle.
    Romera SA; Puntel M; Quattrocchi V; Del Médico Zajac P; Zamorano P; Blanco Viera J; Carrillo C; Chowdhury S; Borca MV; Sadir AM
    BMC Vet Res; 2014 Jan; 10():8. PubMed ID: 24401205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A glycoprotein E gene-deleted bovine herpesvirus 1 as a candidate vaccine strain.
    Weiss M; Brum MC; Anziliero D; Weiblen R; Flores EF
    Braz J Med Biol Res; 2015 Sep; 48(9):843-51. PubMed ID: 26200229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of a glycoprotein E-deleted bovine herpesvirus type 1 strain in the field.
    Dispas M; Schynts F; Lemaire M; Letellier C; Vanopdenbosch E; Thiry E; Kerkhofs P
    Vet Rec; 2003 Aug; 153(7):209-12. PubMed ID: 12956298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virulence, immunogenicity and reactivation of bovine herpesvirus 1 mutants with a deletion in the gC, gG, gI, gE, or in both the gI and gE gene.
    Kaashoek MJ; Rijsewijk FA; Ruuls RC; Keil GM; Thiry E; Pastoret PP; Van Oirschot JT
    Vaccine; 1998 May; 16(8):802-9. PubMed ID: 9627937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic and pathogenic studies on a glycoprotein E variant field isolate of bovine herpesvirus 1.
    Egyed L; Ros C; Belák S
    Vet Res Commun; 2000 Sep; 24(6):423-31. PubMed ID: 11014611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction and growth properties of bovine herpesvirus type 5 recombinants defective in the glycoprotein E or thymidine kinase gene or both.
    Brum MC; Weiblen R; Flores EF; Chowdhury SI
    Braz J Med Biol Res; 2010 Feb; 43(2):217-24. PubMed ID: 19893987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a triplex real-time PCR assay for the rapid detection and differentiation of wild-type and glycoprotein E-deleted vaccine strains of Bovine herpesvirus type 1.
    Wernike K; Hoffmann B; Kalthoff D; König P; Beer M
    J Virol Methods; 2011 Jun; 174(1-2):77-84. PubMed ID: 21458493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of an inactivated, recombinant bovine herpesvirus type 5 (BoHV-5) vaccine.
    Campos FS; Dezen D; Antunes DA; Santos HF; Arantes TS; Cenci A; Gomes F; Lima FE; Brito WM; Filho HC; Batista HB; Spilki FR; Franco AC; Rijsewijk FA; Roehe PM
    Vet Microbiol; 2011 Feb; 148(1):18-26. PubMed ID: 20828945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of a naturally occurring vaccine/wild-type recombinant bovine herpesvirus type 1 (BoHV-1) from an aborted bovine fetus.
    d'Offay JM; Fulton RW; Fishbein M; Eberle R; Dubovi EJ
    Vaccine; 2019 Jul; 37(32):4518-4524. PubMed ID: 31266667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of bovine herpesvirus type 1 by deletion of its glycoprotein G and tk genes and protection against virulent viral challenge.
    Zhang M; Fu S; Deng M; Xie Q; Xu H; Liu Z; Hu C; Chen H; Guo A
    Vaccine; 2011 Nov; 29(48):8943-50. PubMed ID: 21959327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rise and survival of bovine herpesvirus 1 recombinants after primary infection and reactivation from latency.
    Schynts F; Meurens F; Detry B; Vanderplasschen A; Thiry E
    J Virol; 2003 Dec; 77(23):12535-42. PubMed ID: 14610176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A live attenuated glycoprotein E negative bovine herpesvirus 1 vaccine induces a partial cross-protection against caprine herpesvirus 1 infection in goats.
    Thiry J; Tempesta M; Camero M; Tarsitano E; Bellacicco AL; Thiry E; Buonavoglia C
    Vet Microbiol; 2006 Mar; 113(3-4):303-8. PubMed ID: 16330168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virulence and immunogenicity in calves of thymidine kinase- and glycoprotein E-negative bovine herpesvirus 1 mutants.
    Kaashoek MJ; van Engelenburg FA; Moerman A; Gielkens AL; Rijsewijk FA; van Oirschot JT
    Vet Microbiol; 1996 Jan; 48(1-2):143-53. PubMed ID: 8701570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro-generated interspecific recombinants between bovine herpesviruses 1 and 5 show attenuated replication characteristics and establish latency in the natural host.
    Del Medico Zajac MP; Romera SA; Ladelfa MF; Kotsias F; Delgado F; Thiry J; Meurens F; Keil G; Thiry E; Muylkens B
    BMC Vet Res; 2011 May; 7():19. PubMed ID: 21592326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical protection against caprine herpesvirus 1 genital infection by intranasal administration of a live attenuated glycoprotein E negative bovine herpesvirus 1 vaccine.
    Thiry J; Tempesta M; Camero M; Tarsitano E; Muylkens B; Meurens F; Thiry E; Buonavoglia C
    BMC Vet Res; 2007 Dec; 3():33. PubMed ID: 18053233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A gE deleted infectious bovine rhinotracheitis marker vaccine for use in improved bovine herpesvirus 1 control programs.
    Strube W; Auer S; Block W; Heinen E; Kretzdorn D; Rodenbach C; Schmeer N
    Vet Microbiol; 1996 Nov; 53(1-2):181-9. PubMed ID: 9011010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.